CoChat

Perspectives of drug treatment and mental health professionals towards treatment provision for substance use disorders with coexisting mental health problems in England

Open access

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Background: Opioid-related deaths are at record levels in the UK and contribute to over half of all drug-related deaths. The prevalence of psychiatric disorders within people who uses substances is known to be considerably higher than the general population, yet only 4% of people accessing treatment are thought to receive integrated care for coexisting conditions. This study aimed to explore perspectives on treatment for people with substance use disorders and coexisting psychiatric problems. Methods: Face-to-face semi-structured interviews with community drug workers, specialist nurses, prescribing administration worker and one clinical psychologist were conducted. Deductive analysis of three preconceived themes (i.e. reasons for substance use, treatment provision, the role of medication) was conducted. Results: There was agreement between drug treatment professionals and mental health professionals for the complexities for being in treatment for people who use substances. An expectancy of prolonged periods of abstinence from drug and alcohol use before psychological treatment would be initiated leading to relapse was reported. Individual judgements of practitioners, stigmatisation and fear of people who use substances and organisational barriers often meant psychological help was unavailable which contributed to a reliance on medication, against national clinical guidance which was known by only one interviewee. Conclusion: The UK drug treatment and mental health services should review the pathways to ensure that national guidelines are followed so that people who use substances are not excluded from accessing psychological therapies. Data from the coronavirus pandemic indicates heightened psychiatric problems, where illicit drug use may escalate as a means of self-medication leading to further increases in drug-related deaths.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/20503245211055382

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Figures

Image 1
CC-BY-NC · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Research works printed but not linked: 8

  1. AllsoppK,ReadJ,CorcoranR,etal.(2019)Heterogeneityinpsychiatric diagnostic classi fi cation. Psychiatry Research : 279: 15 -22.
  2. El fi l M and Negida A (2017) Sampling methods in clinical research; an educational review. Emergency (Tehran, Iran) 5 (1): e52.
  3. Houghton B, Bailey A, Kouimtsidis C, et al. 2020. Targeting opioid-related deaths: prevalence, perspectives and the potential role of oxytocin . Unpublished doctoral thesis. St Georges University of London, London
  4. NHS Digital (2017) Prescriptions Dispensed in the Community, Statistics for England -2006 -2016: Trend Tables [online] .
  5. NICE (2019) Coexisting severe mental illness and substance misuse quality standard. Draft for consultation 2019 : 2 -26.
  6. Of fi ce for National Statistics (2021) Deaths related to drug poisoning in england and wales: 2020 registrations. Office for National Statistics 1 -13.
  7. Patel RS, Elmaadawi A, Nasr S, et al. (2017) Comorbid posttraumatic stress disorder and opioid dependence. Cureus 9 (9): e1647.
  8. World Health Organization, 2016, mhGAP Intervention Guide - Version 2.0 for Mental, Neurological and Substance Use Disorders in Non-Specialized Health Settings

Cited by

See all 5

Metadata

Authors
Houghton, B., Bailey, A., Kouimtsidis, C., Duka, T., & Notley, C.
Affiliations
  • St George's, University of London (GB)
  • Imperial College London (GB)
  • University of Sussex (GB)
  • University of East Anglia (GB)
Corresponding author
Houghton, Ben
Venue
Drug Science, Policy and Law
Published
2021-01
Volume
7
ISSN
2050-3245 (ISSN-L)
OpenAlex
W3216817140
Cited by
5
References
22
Citations by year
2026: 1 · 2024: 4
FWCI
0.72
Type
journal article
Language
en
Open access
Locations
  • Drug Science Policy and Law (publishedVersion, cc-by-nc)
  • St George's Online Research Archive (St George's University of London) (acceptedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords
substance use disorders, integrated care, community drug services, mental health professionals, stigma, medication use, opioid-related deaths, relapse, clinical guidelines adherence, self-medication, COVID-19 pandemic, England

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Perspectives of drug treatment and mental health professionals towards treatment provision for substance use disorders with coexisting mental health problems in England. https://app.cochat.ai/papers/10.1177/20503245211055382
The paper
Houghton, B., Bailey, A., Kouimtsidis, C., Duka, T., & Notley, C. (2021). Perspectives of drug treatment and mental health professionals towards treatment provision for substance use disorders with coexisting mental health problems in England. Drug Science, Policy and Law. https://doi.org/10.1177/20503245211055382

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.